DiscoverHemeTalks: Conversations in Hematology EducationAdvancing Sickle Cell Disease Care: A conversation between cellular therapy & BMT providers
Advancing Sickle Cell Disease Care: A conversation between cellular therapy & BMT providers

Advancing Sickle Cell Disease Care: A conversation between cellular therapy & BMT providers

Update: 2024-12-19
Share

Description

Are you a healthcare professional seeking clarity on the evolving treatments for sickle cell disease (SCD)? 

In this 20-minute episode, experts from cellular therapy and bone marrow transplantation (BMT) explore key updates in SCD care, including curative therapies, gene-editing innovations, and BMT approaches. They address practical challenges in integrating these treatments into practice and discuss strategies to improve access and outcomes. Tune in to discover how collaboration between cellular therapy and BMT providers is transforming care and paving the way for better patient experiences. 

 

Learning Objectives 

  1. Understand recent advancements in curative therapies, including gene editing and BMT, for sickle cell disease. 
  2. Identify key challenges and barriers to integrating new treatments into clinical practice for SCD patients. 
  3. Explore collaborative care strategies between cellular therapy and BMT providers to improve patient outcomes and access. 
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Advancing Sickle Cell Disease Care: A conversation between cellular therapy & BMT providers

Advancing Sickle Cell Disease Care: A conversation between cellular therapy & BMT providers

American Society of Hematology